Eivor Örnskov, Ph.D.

Principal Scientist, Pharmaceutical Sciences at AstraZeneca Gothenburg

Speaker

Eivor Örnskov is a Principal Scientist at AstraZeneca in Gothenburg, Sweden, where she leads development of the analytical characterization platform for the company’s novel lipid nanoparticle (LNP) drug products. She earned her PhD in analytical chemistry from Uppsala University in 2004. At AstraZeneca, Eivor has developed numerous release and stability methods that support both preclinical and clinical programs. She has also authored regulatory submissions and published peer-reviewed work about mRNA characterization.